In this role, Mr. Blake will lead the development, assessment, and execution of critical IT strategies across BioAgilytix’s international operations to support the company’s continued growth and position as a technologically-advanced bioanalytical services provider.
BioAgilytix has announced several promotions within its leadership team. PD Dr. Arno Kromminga has been promoted to Global Chief Scientific Officer, and will lead BioAgilytix’s global scientific strategy while also continuing to serve as the European Managing Director. Beth Heinz has been promoted to Vice President of Global Business Development and will continue her focus on cultivating and managing both strong client relationships and strategic partnerships worldwide.
BioAgilytix has announced an agreement to be acquired by Cobepa S.A., a privately-held investment company. The acquisition by Cobepa will provide BioAgilytix with increased funding and resources to meet growing demand for its high-quality services, driven by its strong scientific reputation and leading expertise in biologics development.
BioAgilytix has been named as one of Triangle Business Journal’s Fast 50 Award winners for 2018. This award is designed to honor those privately held companies in the Triangle Park area that have demonstrated remarkable growth in the past three years.
BioAgilytix and Marshall University are partnering to host a career information session and recruitment event for science majors at Marshall’s Huntington, West Virginia campus on October 18, 2018. The event is aimed at educating students with degrees in Biology, Chemistry, and related science fields on the career opportunities available to them in the pharmaceutical and biotechnology industry, including within contract research organizations (CROs) such as BioAgilytix.
BioAgilytix has announced a new expansion plan for its USA headquarters located in the Research Triangle area of North Carolina. The company will be developing out an additional 21,173 square foot building directly adjacent to its existing facility – nearly half of which will be dedicated laboratory space – to bring the campus’ total footprint to over 69,000 square feet.
For the Fifth Time in Six Years, the Bioanalytical Laboratory Earns an Exclusive Ranking AUGUST 15, 2018—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large…
The Bioanalytical Laboratory is Honored with Award for the Third Time, Highlighting the Company’s Ongoing Commitment to Diversity in the Workplace AUGUST 13, 2018—Durham, NC—BioAgilytix, a leading provider of contract…
Inclusive Diversity Policies and Programs Help the Company to Recruit a Wide Variety of Global Talent to its USA and European Headquarters JULY 17, 2018—Durham, NC—BioAgilytix, a leading provider of…
JULY 11, 2018—Richmond, BC, Guilford, CT and Durham, NC—Bioasis Technologies, Inc. (TSX.V:BTI; OTCQB:BIOAF), a biopharmaceutical company developing its xB3™ proprietary platform technology for the delivery of therapeutics across the blood-brain…
Services
Platforms